EDGAR Filing Documents for 0001104659-16-121093

Form 8-K - Current report:

SEC Accession No. 0001104659-16-121093

Filing Date

2016-05-16

Accepted

2016-05-16 06:42:04

Documents

Period of Report

2016-05-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a16-11280_18k.htm	8-K	29409
2	EX-99.1	a16-11280_1ex99d1.htm	EX-99.1	110431
3	GRAPHIC	g112801mm01i001.jpg	GRAPHIC	2330
	Complete submission text file	0001104659-16-121093.txt		144539

Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050

Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360

Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)